Danazol is a synthetic steroid derivative with agonist-antagonist properties, primarily prescribed for the treatment of endometriosis, hereditary angioedema, fibrocystic breast disease, and various other… Read more
Danazol is a synthetic steroid derivative with agonist-antagonist properties, primarily prescribed for the treatment of endometriosis, hereditary angioedema, fibrocystic breast disease, and various other hormonal conditions. This category provides essential pharmaceutical reference standards for Danazol, alongside a comprehensive selection of its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These high-quality reference materials are critical for laboratories performing impurity profiling, method validation, and rigorous quality control. By utilizing these precise analytical standards, researchers can ensure the accurate identification and quantification of Danazol during pharmaceutical development and stability testing. Whether for routine batch analysis or complex regulatory compliance, these products support the necessity of maintaining stringent safety and efficacy standards throughout the drug manufacturing lifecycle.